1ISG-001 Can rivaroxaban become cost saving compared with vitamin K antagonists in the treatment of patients with non-valvular atrial fibrillation in France? von Robert, S, Vincent, F, Vengadessane, S

Volltext

4CPS-167 Assessment of adherence to immunosuppressive therapy in kidney-transplanted patients von Vengadessane, S, Roy, C Le, Sauvageon, H, Madelaine, I, Pillebout, E, Viglietti, D, Deville, L

Volltext

PP-021 Evaluation of the surface contamination in a chemotherapy preparation unit before a process change von Vengadessane, S, Carre, N, Jobard, M, Brandely-Piat, ML, Chast, F

Volltext

Vascular calcifications, the hidden side effects of vitamin K antagonists von Bennis, Youssef, Vengadessane, Subashini, Bodeau, Sandra, Gras, Valérie, Bricca, Giampiero, Kamel, Saïd, Liabeuf, Sophie

Volltext

Comparison of Duration of Analgesic Comparison of Duration of Analgesic Effect of Nalbuphine and Morphine as an Adjuvant to Bupivacaine in the Supraclavicular Block under Ultrasoun... von Vengadessane, Aruna, Rajaraman, Jayashri Devi, Raghuraman, M. S., Prabu, R. Krishna, Damodaran, Srilekha, Sabu, Britto

Volltext

Les calcifications vasculaires sous anti-vitamines K : un effet indésirable méconnu von Bennis, Youssef, Vengadessane, Subashini, Bodeau, Sandra, Gras, Valérie, Bricca, Giampiero, Kamel, Saïd, Liabeuf, Sophie

Volltext

État des lieux de l’utilisation du chlorure de potassium injectable en vue du référencement de solutions prêtes a l’emploi von Vengadessane, Subashini, Le Roy, Clémentine, Madeleine, Isabelle, Touratier, Sophie, Deville, Laure

Volltext